Eliav Winton


Eli Winton provides technical, scientific, and regulatory support for pharmacology and toxicology projects in multiple therapeutic areas.  He provides support for outsourcing and study monitoring activities, nonclinical project management, and authoring regulatory submission documents (Investigational New Drug Applications [INDs] and New Drug Applications [NDAs]).  He also assists in the preparation and review of regulatory submissions, including performing quality control reviews. Prior to joining SciLucent, Eli completed a full-year co-op at Champions Oncology CRO in their Ex-vivo and R&D departments where he assisted in large scale Acute‑Myeloid Leukemia (AML) drug screens along with Tumor-infiltrating Lymphocyte (TIL) assay development. Eli has a B.S. in Chemical and Biomolecular Engineering from the University of Maryland.